SOLARA Solara Active Pharma Sciences Ltd Business Restructuring Announcement 2025 - Board Meeting Update Solara Active Pharma Sciences approved its unaudited financial results for the Q3 and nine months ended December 31, 2024, and is exploring a potential demerger of its CRAMS and Polymers business into a separate listed entity..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Solara Active Pharma Sciences Ltd